Abstract:BACKGROUND: The incidence of hepatocellular carcinoma (HCC) in China is closely related to the population infected with hepatitis B virus (HBV). HCC cells with HBV secrete soluble HBsAg into blood but do not express it on the cell membrane. This study aimed to construct and investigate a new glycosylphosphatidylinositol (GPI)-anchored protein (GPC3+alpha+EGFP) as a DNA vaccine against HCC associated with HBV.METHODS: A recombinant plasmid (pcDNA3.1(+)/GPC3+alpha+EGFP) was constructed and verified by restriction endonuclease digestion and sequencing. pcDNA3.1(+)/GPC3+alpha+EGFP was transfected into HepG2 cells (experimental group) using lipofectamine 2000. pEGFP-N1-transfected HepG2 cells were used as a negative control, and non-transfected HepG2 cells sreved as a blank control. HepG2 cells that steadily expressed the fusion protein GPC3+alpha+EGFP were screened by G418, propagated, and co-cultured with lymphocytes from healthy donors. Cell proliferation was measured by the classic sulforhodamine B assay. Apoptosis was assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and Fas gene transcription was determined by quantitative fluorescent PCR.RESULTS: The pcDNA3.1(+)/GPC3+alpha+EGFP plasmid was successfully constructed. In the experimental group, green fluorescence was observed at the cell periphery and in the cytoplasm, whereas in the negative control group, fluorescence was evenly distributed throughout the cell. Proliferation of the experimental group significantly decreased after 72 hours compared to the negative and blank control groups. Furthermore, the number of apoptotic cells was statistically different among the three groups as determined by a contingency table Chi-square test; the experimental group had the highest incidence of apoptosis. Fas gene transcription in the experimental group was higher than in the two control groups, and an increasing trend with time in the experimental group was observed.CONCLUSION: A chimeric, membrane-anchored protein, GPC3+alpha+EGFP, localized to the membrane of HepG2 cells and inhibited proliferation and accelerated apoptosis through a Fas-FasL pathway after co-cultivation with lymphocytes.

Identification of the β2 GP Ⅰ -binding receptor on hepatocyte membrane

The Expressions of P-gp and P38 Protein in Human Hepatocellular Carcinoma

Identification of Differential HLA-binding Peptide Between Two Hepatoma Cell Lines HepG2 and HepG2.2.15

[An Analysis of Annexin II Related to HCC Metastatic Ability].

M2BPgs-HCC: An Automated Multilectin Bead Array Indicating Aberrant Glycosylation Signatures Toward Hepatitis C Virus-Associated Hepatocellular Carcinoma Prognosis

Identification of G Protein Subunit Alpha I2 As a Promising Therapeutic Target of Hepatocellular Carcinoma

Screening and characterization of hepatic B virus Pre-S2 binding proteins by phage display system

Screening and Identification of Interacting Proteins with Hepatitis B Virus Core Protein in Leukocytes and Cloning of New Gene C1

Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray.

Tissue Transglutaminase 2 Exerts a Tumor-Promoting Role in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Gpc3 Fused to an Alpha Epitope of Hbsag Acts As an Immune Target Against Hepatocellular Carcinoma Associated with Hepatitis B Virus

Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi

Identification of N-glycosylation Sites on Secreted Proteins of Human Hepatocellular Carcinoma Cells with a Complementary Proteomics Approach.

Screening for serum binding proteins in subjects with primary hepatocellular carcinoma using a phage display system

Screening, Expression and Characterization of a Novel Protein Binding to Hepatitis B Surface Antigen

Protein Expression and Fucosylated Glycans of the Serum Haptoglobin-Beta Subunit in Hepatitis B Virus-Based Liver Diseases

Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis

Identification of nanobodies against hepatocellular carcinoma marker glypican-3

Diagnostic value of angiopoietin-like protein 2 for CHB-related hepatocellular carcinoma.

Subcellular Proteome Analysis Unraveled Annexin A2 Related to Immune Liver Fibrosis

Identification of Beta-1,4-Galactosyltransferase I As A Target Gene of Hbx-Induced Cell Cycle Progression of Hepatoma Cell